Owners, management and financials
CVR: 44226189
DKK -483,088
Gross profit
Net result: DKK -3,540,377
Northgaard Holding ApS (5-9,99%), Ditte Boilesen Holding ApS (33,33-49,99%)
1 more
CVR · view owners
Ditte Rahbæk Boilesen, Stephanie Holstein-Rønsbo
Board: Alejandra Maria Cristina Bonifacini Mørk (chair) and 3 members
CVR · view management
Active
Founded 9 August 2023
CVR · view overview
6 employees
CVR · 2026
Owner registered: Northgaard Holding ApS
CVR · 13/01/2025
View the full event history
Loma Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2023. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Ditte Rahbæk Boilesen and Stephanie Holstein-Rønsbo. The board consists of Alejandra Maria Cristina Bonifacini Mørk (chair), Leif Helth Jensen, Ralf Wagner and Stuart John Myles Collinson. The company is owned by Northgaard Holding ApS, Ditte Boilesen Holding ApS and Holstein-Rønsbo Holding ApS. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK -483,088 and a net result of DKK -3,540,377. Equity in the 2025 report amounted to DKK -8,121,947.
Selskabets formål er at foretage forskning, udvikling og kommercialisering inden for medicinske produkter.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -483K | -3.5M | 7.3M | -8.1M | 5 |
Compared to 1.034 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningThe CVR number of Loma Therapeutics ApS is 44226189.
Loma Therapeutics ApS is owned by Northgaard Holding ApS, Ditte Boilesen Holding ApS and Holstein-Rønsbo Holding ApS.
The management of Loma Therapeutics ApS consists of Ditte Rahbæk Boilesen and Stephanie Holstein-Rønsbo.
The board of Loma Therapeutics ApS consists of Alejandra Maria Cristina Bonifacini Mørk, Leif Helth Jensen and Ralf Wagner, with Alejandra Maria Cristina Bonifacini Mørk as chair.
In 2025, Loma Therapeutics ApS reported a gross profit of DKK -483,088.
Loma Therapeutics ApS had 6 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Loma Therapeutics ApS has published its annual report for 2025. Gross profit came to DKK -483,088, and the net result was DKK -3,540,377.
As of May 22, 2026, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Loma Therapeutics ApS.
Loma Therapeutics ApS has published its interim report for the period August 9, 2023 to December 31, 2024.
As of January 13, 2025, Alejandra Maria Cristina Bonifacini Mørk has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Leif Helth Jensen has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Stuart John Myles Collinson has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Ralf Wagner has joined the board of directors of Loma Therapeutics ApS.
As of January 13, 2025, Northgaard Holding ApS is registered as an owner of Loma Therapeutics ApS with an ownership share of 5%.
As of February 7, 2024, RSM DANMARK STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Loma Therapeutics ApS.
As of February 7, 2024, Taastrup 2024 P/S has stepped down as auditor of Loma Therapeutics ApS.
As of August 9, 2023, Taastrup 2024 P/S has been appointed auditor of Loma Therapeutics ApS.
As of August 9, 2023, Ditte Rahbæk Boilesen is registered as director of Loma Therapeutics ApS.
As of August 9, 2023, Stephanie Holstein-Rønsbo is registered as director of Loma Therapeutics ApS.
As of August 9, 2023, Ditte Boilesen Holding ApS is registered as an owner of Loma Therapeutics ApS with an ownership share of 33%.
As of August 9, 2023, Holstein-Rønsbo Holding ApS is registered as an owner of Loma Therapeutics ApS with an ownership share of 33%.
Loma Therapeutics ApS was founded on August 9, 2023.

Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.

Selskabets formål er at drive virksomhed med handel og produktion samt hermed beslægtet virksomhed.

Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed

Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.

Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Companies in the same industry and area
CVR 46481585
CVR 36465972
CVR 45436497
CVR 46059220
CVR 41978074